Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy
1. 请及时下载文件确认是否正确, 系统将在 2025-08-08 17:08:55 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
H Al-Samkari, JM Connors
… 2014, the American Society of …, 2019
ashpublications.org
… and competing risks of clotting and bleeding in these patients … regular anti-Xa monitoring with dose adjustment is feasible) … D-dimer measurement is less helpful in patients with cancer …